Philip Awadalla has been studying population genetics for decades, and is still amazed at what scientists have learned from comparing genomes at scale. “There have been massive advancements in our ...

Illumina has recently advanced its plan to divest its cancer-diagnostics unit, a move intended to ease regulatory pressure and sharpen its focus on core DNA sequencing and microarray technologies.

Key opportunities in the Global Immunoprecipitation Market include rising demand driven by genomic/proteomic research for drug discovery, increased investment in life sciences, and advancements in AI ...

The RNA analysis market is poised for significant growth due to rising demand in precision medicine, advancements in NGS technologies, and expanding use of RNA biomarkers in diagnostics and drug ...